Wendy Green
Psychiatric/Mental Health · Athens, ALNPI 1295906634
Payments from drug & device makers
Across 42 payments — averaging $31.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Indivior Inc.$391
- Inspire Medical Systems, Inc.$338
- Alkermes, Inc.$192
- Braeburn Inc.$127
- Gilead$61
- Vanda Pharmaceuticals Inc.$50
- plus $147 from 6 others
What the payments were for
- Travel & lodging$33826%
- Food & beverage$96874%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Indivior Inc. | 16 | $391 |
| Inspire Medical Systems, Inc. | 1 | $338 |
| Alkermes, Inc. | 9 | $192 |
| Braeburn Inc. | 5 | $127 |
| Gilead | 3 | $61 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
| Harmony Biosciences LLC | 1 | $28 |
| Johnson & Johnson | 1 | $24 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $23 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $20 |
| Jazz Pharmaceuticals Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Inspire$338
How this compares
$1,306 in reported general payments places this provider in the 55th percentile of 378 psychiatric/mental health providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 418 | $69,082 |
| Quetiapine Fumarate | 40 | $589 |
| Duloxetine Hcl | 22 | $326 |
| Gabapentin | 38 | $320 |
| Buspirone Hcl | 13 | $154 |
| Tizanidine Hcl | 20 | $125 |
| Metoprolol Succinate | 12 | $71 |
| Trazodone Hcl | 15 | $61 |
| Cyclobenzaprine Hcl | 12 | $41 |
| Escitalopram Oxalate | 17 | $37 |
| Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide | 11 | $27 |
| Clonazepam | 12 | $15 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Athens
- Laura GrahamMontgomery$80K
- Yuliya SpencerBirmingham$65K
- Keri BarrBay Minette$35K
- John HayesMobile$30K
- Logan ThrasherHoover$22K
- Anthony PhillipsHelena$15K
- Ian KinzerHuntsville$15K
- Latisha AliHoover$15K
- Taylor BarrettGadsden$15K
- Angela GarrardGadsden$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.